Analysis

AeroVironment Shares Slide on Restatement, SCAR Backlog Concerns

AeroVironment shares plunged 10.8% after an amended 10-Q showed a larger net loss and that $1.49 billion in SCAR options are no longer expected, sparking concerns over backlog quality.

Daniel Marsh · · · 3 min read · 8 views
AeroVironment Shares Slide on Restatement, SCAR Backlog Concerns
Mentioned in this article
AVAV $151.33 -10.78% KTOS $51.09 -5.76% LMT $493.60 -3.40% NOC $507.33 -2.72%

AeroVironment (NASDAQ: AVAV) experienced a sharp decline on Monday, with shares dropping 10.8% to close at $151.33. The sell-off followed the company's filing of an amended 10-Q and an 8-K related to a goodwill error restatement that revealed a larger net loss and a new internal control weakness. Trading volume more than doubled its average, reflecting heightened investor anxiety ahead of the company's fiscal fourth-quarter earnings and investor day.

Restatement Details

The amended filing for the quarter ended January 31 showed that a goodwill analysis error in the Space unit understated the loss from operations by $89.4 million and net loss by $87.3 million. Goodwill represents the accounting value assigned to anticipated benefits from an acquisition above the value of tangible assets. Importantly, the restatement did not affect reported revenue, current assets, current liabilities, or cash from operations, indicating no loss of sales or customer payments. Instead, it reflected a more aggressive write-down of the Space business's value.

Backlog Quality Under Scrutiny

Investor focus is now on the quality of AeroVironment's backlog. The amended filing disclosed that as of January 31, unfunded backlog stood at $2.97 billion, but $1.49 billion of that consisted of unexercised SCAR (Satellite Communication Augmentation Resource) options that are no longer expected to be awarded. Unfunded backlog represents future work not yet committed by the customer, and such a large portion being withdrawn raises questions about the reliability of headline backlog figures.

SCAR Program Challenges

The SCAR program has been a persistent issue for AeroVironment. The company revealed that on March 10, the U.S. government notified it of an intention to terminate for convenience the contract for BADGER phased-array antenna systems. While AeroVironment can still pursue future SCAR projects, a termination for convenience allows the government to end contracts without default. This development casts doubt on the company's growth trajectory in the space communications sector.

Internal Control Weakness

The restatement also highlighted a material weakness in internal controls related to the goodwill review process. Management identified a flaw that could allow a significant misstatement to go undetected. AeroVironment plans to implement a quarterly reconciliation control, but the company cautioned that the weakness cannot be considered fully addressed until the new controls have operated effectively for a sufficient period.

Governance Changes

Adding to the turmoil, the company announced that directors David Wodlinger and Henry Albers left the board effective June 17. Both individuals, who were representatives of Arlington Capital Partners following the BlueHalo deal, stated there was no dispute with management behind their departures. Arlington Capital retains the right to appoint two new directors, according to the filing.

Market Context and Outlook

Despite these setbacks, AeroVironment's core drone business remains strong. In March, CEO Wahid Nawabi highlighted robust demand for the company's unique solutions, citing stronger order flow and a record $1.1 billion in funded backlog. The amended filing, however, shifts focus to funded backlog as the more reliable metric, while unfunded SCAR options appear increasingly uncertain. The stock's decline may be overdone if next week's earnings show growth in funded drone orders, loitering munitions, or counter-drone systems, or if management presents credible SCAR replacement options at the July 8 investor day. Conversely, continued control, margin, or contract-conversion issues could lead to further underperformance, especially as peers like Kratos, Lockheed Martin, and Northrop Grumman also fell on Monday.

Investors are advised to monitor the upcoming earnings report and investor day for clarity on the company's growth path and the impact of the SCAR program uncertainties.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →